Journal List > Lab Med Online > v.6(3) > 1057309

Yim, Lee, Cho, Won, and Kim: Performance Evaluation of the CLINITEK Novus Automated Urine Chemistry Analyzer

Abstract

Background

We aimed to evaluate the performance of the CLINITEK Novus urine chemistry analyzer (Siemens, UK).

Methods

The precision, correlation, and carryover study were performed using two kinds of commercial quality control materials and 40-55 freshly collected patient specimens. We calculated exact and within-1-block agreement, along with kappa agreement, to compare the semi-quantitative results between urine chemistry analyzers. The urine specific gravity taken by a refractometer was compared with the analyzer results. Moreover, we analyzed additional urine specimens for protein to evaluate the agreement of results between those of the CLINITEK Novus and the AU680 analyzers (Beckman Coulter, Japan).

Results

The precision study showed acceptable results; within-1-block agreement was 100% in all tested items. The urine chemistry results from the CLNITEK Novus analyzer demonstrated ≥85.1% within-1-block agreements with those of the Uriscan Super, and the kappa test results were ≥0.81. The comparison of specific gravity with manual refractometer showed a good correlation (r=0.991), and the protein comparison with the AU680 analyzer also showed a good correlation (with exact and within-1-block agreements being 75.9% and 100.0%, respectively). The carryover rates were 0% in all tested items, except specific gravity and heavy blood tests.

Conclusions

The CLINITEK Novus analyzer showed good performance in terms of precision, comparison, and carryover in this study. Therefore, the CLINITEK Novus automated urine analysis is expected to be useful for routine urinalysis in a clinical laboratory.

Figures and Tables

Fig. 1

Agreement and correlation of specific gravity between (A) the CLINITEK Novus analyzer and a refractometer, (B) Uriscan Super and a refractometer, (C) CLINITEK Novus and Uriscan Super.

lmo-6-147-g001
Table 1

Semiquantitative level grading criteria for the CLINITEK Novus and Uriscan Super analyzers according to their package inserts

lmo-6-147-i001
Instrument Negative ± 1+ 2+ 3+ 4+ Unit
Protein CLINITEK Novus - - 30 100 300 2,000 mg/dL
Uriscan Super - 10 30 100 300 1,000 mg/dL
Glucose CLINITEK Novus - 100 250 500 1,000 2,000 mg/dL
Uriscan Super - 100 250 500 1,000 2,000 mg/dL
Ketone CLINITEK Novus - 5 15 40 80 160 mg/dL
Uriscan Super - 5 10 50 100 - mg/dL
Occult blood CLINITEK Novus - Trace Small Moderate Large - -
Uriscan Super - - 10 50 250 - RBC/µL
Leukocytes CLINITEK Novus - Trace Small Moderate Large - -
Uriscan Super - - 25 75 500 - WBC/µL
Table 2

Precision analyzed by the CLINITEK Novus analyzer using CLINITEK Novus Control Strips and Liquichek Urinalysis Controls for 11 test parameters (N=20)

lmo-6-147-i002
Strips Bilirubin Occult blood Agreement (%), Exact agreement/within-1-block agreement
Clarity Color Glucose Ketone WBCs Nitrite pH Protein Urobilinogen
NOVUS CONTROLS Level 1 100/100 100/100 100/100 100/100 100/100 100/100 100/100 100/100 100/100 100/100 100/100
Liquichek Level 1 100/100 100/100 -* -* 100/100 100/100 100/100 100/100 100/100 100/100 100/100
NOVUS CONTROLS Level 2 100/100 100/100 100/100 100/100 100/100 85/100 95/100 100/100 100/100 65/100 100/100
Liquichek Level 2 100/100 100/100 -* -* 70/100 65/100 100/100 100/100 100/100 60/100 100/100

*Liquichek controls have no items for clarity and color.

Table 3

Precision of specific gravity analyzed by the CLINITEK Novus analyzer

lmo-6-147-i003
Test Material Expected value Mean SD %CV
Specific gravity NOVUS CONTROLS Level 1 ≤ 1.006 1.002 0.0009 0.090
Liquicheck Level 1 1.005-1.020 1.013 0.0009 0.001
NOVUS CONTROLS Level 2 1.004-1.014 1.010 0.0014 0.139
Liquicheck Level 2 1.015-1.030 1.022 0.0011 0.108
Table 4

Agreement percentages and kappa values of protein, glucose, ketone, occult blood, leukocytes, and pH using the CLINITEK Novus and Uriscan Super analyzers

lmo-6-147-i004
Sample no. Complete agreement (%) Within-1-block agreement
(%)
Positive/negative agreement
(%)
κ
Protein 47 40.4 85.1 100.0 0.81
Glucose 55 54.6 94.6 94.5 0.90
Ketone 43 72.1 100.0 95.3 0.93
Occult blood 40 80.0 100.0 97.5 0.96
Leukocytes 50 68.0 100.0 90.0 0.91
pH 41 41.5 97.6 - 0.91
Table 5

Agreement of urine protein between the CLINITEK Novus analyzer and quantitation by the AU680 analyzer (grade, N=29)

lmo-6-147-i005
CLINITEK Novus AU680*
Negative ± 1+ 2+ 3+ 4+
Negative 6 1
± 3
1+ 5 1
2+ 2 4 2
3+ 4 1
4+

Complete agreement: 75.9%; Within-1-block agreement: 100.0%; Positive/negative agreement: 100.0%; Kappa test: 0.94. *Protein concentrations measured by the AU680 analyzer were graded according to the dipstick package insert (Siemens, NY, USA), grade (equivalent concentration); Negative, ±, 1+(30 mg/dL), 2+(100 mg/dL), 3+(300 mg/dL), 4+(2,000 mg/dL).

Notes

This article is available from http://www.labmedonline.org

References

1. Kim KD. Urinalysis. In : Kang , editor. The Korean Society for Laboratory Medicine. Laboratory medicine. 5th ed. Seoul: E*PUBLIC;2014. p. 497–508.
2. McPherson RA, Ben-Ezra J. Basic examination of the urine. In : Henry JB, editor. Clinical diagnosis and management by laboratory methods. 22nd ed. Philadelphia: WB Saunders;2011. p. 445–479.
3. Han TH. Urinalysis: the usefulness and limitations of urine dipstick testing. J Korean Soc Pediatr Nephrol. 2013; 17:42–48.
crossref
4. Park HR, Jeong BK, Park NW. Comparative evaluation of dipstick urinalysis by dipstick readers. J Clin Pathol Qual Control. 2001; 23:239–246.
5. Clinical and Laboratory Standards Institute. User verification of precision and estimation of bias; Approved guideline-Third Edition. EP15-A3. Third Edition. Wayne, PA: Clinical and Laboratory Standards Institute;2014.
6. Clinical Laboratory Standards Institute. Urinalysis; Approved Guideline-Third Edition. GP16-A3. Wayne, PA: Clinical Laboratory Standards Institute;2012.
7. Skitek M. Imprecision and instability of common analytes in urine analysed by semi-automated dipstick urinalysis. Accred Qual Assur. 2004; 9:700–703.
crossref
TOOLS
Similar articles